Has Nadege Gunn received payments from drug or device companies?

Yes. Drug and device makers reported $5,707,588 in general payments to Nadege Gunn across 1,721 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nadege Gunn did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nadege Gunn come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nadege Gunn

Gastroenterology · Waco, TXNPI 1902822281

Payments from drug & device makers

$5,707,588in general payments, 2019–2025

Across 1,721 payments — averaging $3316.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Gilead$938K
E.r. Squibb & Sons, L.L.C.$934K
Boehringer Ingelheim International GmbH$559K
Vertex$494K
Boehringer Ingelheim$488K
Eli Lilly$487K
plus $1.8M from 42 others

$5,260in research payments, 2019–2025

Across 9 payments — averaging $584.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

E.r. Squibb & Sons, L.L.C.$3K
Eli Lilly$2K
Gilead$145
Novo Nordisk AS$121
GSK$40

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Gilead	358	$938,094
E.r. Squibb & Sons, L.L.C.	9	$933,667
Boehringer Ingelheim International GmbH	375	$559,138
Vertex	6	$493,878
Boehringer Ingelheim	143	$488,054
Eli Lilly	29	$486,962
Bausch Health US, LLC	62	$377,573
Madrigal Pharmaceuticals	209	$371,507
Pfizer	39	$301,070
Genentech, Inc.	20	$264,273
Novo Nordisk	75	$133,407
Ipsen Biopharmaceuticals, Inc	52	$73,948
Braintree Laboratories, Inc.	10	$51,925
GSK	19	$50,895
Corcept Therapeutics	10	$43,850
Novo Nordisk AS	37	$37,392
Intercept Pharmaceuticals, Inc.	53	$34,636
Ipsen Bioscience Inc.	8	$24,082
AbbVie	80	$18,797
Mirum Pharmaceuticals, Inc.	12	$6,805
Boehringer Ingelheim Pharma GmbH & Co.kg	1	$6,677
Siemens Medical Solutions USA, Inc.	5	$2,400
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	43	$2,104
Kowa Research Institute, Inc.	9	$1,523
F. Hoffmann-la Roche AG	4	$1,455
Perspectum Diagnostics Ltd	7	$903
Shionogi Inc	5	$797
Takeda Pharmaceuticals U.S.A., Inc.	7	$371
Lilly USA, LLC	7	$208
Dova Pharmaceuticals	4	$190
Exact Sciences	2	$126
Ortho Dermatologics, A Division Of Bausch Health US, LLC	1	$118
Amgen	1	$97
AstraZeneca	1	$97
Janssen Scientific Affairs, LLC	1	$97
Ipsen Pharma SAS	1	$75
UCB, Inc.	3	$67
Romark Laboratories, LC	2	$52
Intuitive Surgical	1	$50
Fujifilm Healthcare Americas Corporation	1	$45
Ultragenyx Pharmaceutical Inc.	2	$41
Albireo Pharma, Inc.	1	$35
Daiichi Sankyo Inc.	1	$22
Alnylam Pharmaceuticals Inc.	1	$20
Echosens North America, Inc.	1	$18
Eisai Inc.	1	$18
Ironwood Pharmaceuticals, Inc	1	$14
Johnson & Johnson	1	$14

How this compares

$5,707,588 in reported general payments places this provider in the 95th percentile of 1,350 gastroenterology providers in Texas.

See all gastroenterology providers in Texas →

Other gastroenterology in Waco

Hanumantha AnchaWaco$1.4M
Eric LawitzSan Antonio$59.5M
George DuvallTyler$17.5M
John FordtranDallas$9.9M
Timothy RitterSouthlake$7.7M
Parvez MantryDallas$6.4M
Mazen NoureddinHouston$6.1M
Michael BrownDallas$5.5M
James MaherHouston$5.3M
Stephen HarrisonLive Oak$5.3M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →